Abstract
While α- and β-synuclein largely overlap in their expression in the vertebrate brain, only α-synuclein accumulates in the fibrillar aggregates typical of Parkinson's disease. It is thus critical to have immunological reagents that distinguish between these two protein isoforms. The monoclonal antibody Syn-1 (Transduction Labs) has been frequently used for the specific detection of α-synuclein. In this report, the epitope for Syn-1 is localized within residues 91-99 of human α-synuclein. Sequence differences exist in this domain that account for the specificity of Syn-1 for α- versus β-synuclein. However, Syn-1 also displays reactivity with additional species (∼45 kDa) in brain homogenates from both wild-type and α-synuclein null mice, indicating a potential for cross-reactivity with a protein species that is unrelated to α-synuclein in brain tissue or extracts.
Original language | English |
---|---|
Pages (from-to) | 133-135 |
Number of pages | 3 |
Journal | Neuroscience Letters |
Volume | 349 |
Issue number | 2 |
DOIs | |
State | Published - Oct 2 2003 |
Keywords
- Breast cancer
- Dopaminergic
- Immunoreactivity
- Knockout
- Parkinson's disease
- Synuclein